Belgium· BE-AMP-SAM448622-00
Xofigo 1100 kBq/ml
A radium (223ra) dichlorid product containing radium (ra-223) dichloride, registered in Belgium by Bayer. The same ATC class is registered in 11 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Radium (223ra) dichlorid is registered in 11 of 19 countries.
Countries holding a registration under ATC V10XX03 (radium (223ra) dichlorid), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Radium (223ra) dichlorid · ATC V10XX03
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Radium (Ra-223) Dichloride
- Manufacturer
- Bayer
- Country
- Belgium (BE)
- ATC code
- V10XX03
- ATC class
- Radium (223Ra) dichlorid
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb3130689
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Radium (223ra) dichlorid in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaXOFIGOBAYER INC
- United KingdomXofigo [Ra-223] 6.6MBq/6ml solution for injection vialsBayer Plc
- IrelandXofigo 1100 kBq/mL solution for injectionBayer AG
- NorwayXofigoBayer AG
- SwedenXofigo 1100 kBq/ml Injektionsvätska, lösningBayer AG
- United StatesXofigoBayer HealthCare Pharmaceuticals Inc.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Xofigo
- Liechtenstein · Xofigo
- Norway · Xofigo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3a7b8baa-4a27-4f4e-8b09-d1f0993cc688 GET /v1/drugs/3a7b8baa-4a27-4f4e-8b09-d1f0993cc688?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Xofigo 1100 kBq/ml",
"name_fr": "Xofigo 1100 kBq/ml",
"name_nl": "Xofigo 1100 kBq/ml",
"amp_code": "SAM448622-00",
"strengths": [
"1100.0000"
],
"pack_count": 1,
"substances": [
"Radium (Ra-223) Dichloride",
"Sodium Chloride"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Radium (223Ra) Dichloride",
"authorisation_numbers": [
"EU/1/13/873/001"
]
}See everything about radium (223ra) dichlorid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.